Meeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: LBA4001 Authors: Thierry Conroy, Pascal Hammel, Mohamed Hebbar, et. al. Background: FOLFIRINOX is more effective than gem as first-line treatment in metastatic pancreatic cancer for patients (pts) with good performance status. This trial assessed the benefit of mFOLFIRINOX in the...
Pro zobrazení tohoto obsahu je třeba být přihlášen.